Limazocic
Limazocic (SA 3443) is an orally active hepatoprotective agent. Limazocic can inhibit increases in serum transaminase, alkaline phosphatase activity and hepatic lipids, hydroxyproline content induced by CCl4. Limazocic can decrease the degree of hepatic necrosis, fibrosis and steatosis. Limazocic can be used for the research of chronic liver injuries[1].
Product Specifications
CAS Number
[128620-82-6]
Product Name Alternative
SA 3443
UNSPSC
12352005
Hazard Statement
H315-H318-H335-H411
Target
Aminotransferases (Transaminases) ; Phosphatase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
OC([C@H]1NC(C(C)(CSSC1)C)=O)=O
Molecular Formula
C8H13NO3S2
Molecular Weight
235.32
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P501
References & Citations
[1]Ishida N, et al. The protective effects of SA3443, a novel cyclic disulfide, on chronic liver injuries in rats. J Hepatol. 1991 Sep;13 (2) :200-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Spata4 Mouse shRNA Lentiviral Particle (Locus ID 69281)
MAP3K15, NT (MAP3K15, ASK3, Mitogen-activated protein kinase kinase kinase 15, Apoptosis signal-regulating kinase 3, MAPK/ERK kinase kinase 15) (FITC) discontinued